Home CDD

The Centre for Drugs and Diagnostics at the Liverpool School of Tropical Medicine comprises an experienced multi-disciplinary group of experts working together to develop new drugs and diagnostics. Using state-of-the art laboratories and equipment, the group regularly works with industry, academia and other NGOs to discover, develop and deliver novel therapies and diagnostics against a range of pathogens. 

Latest

The A∙WOL antifilarial drug discovery team. News article A∙WOL antifilarial drug discovery team win prestigious Royal Society of Chemistry Prize From: LSTM A∙WOL antifilarial drug discovery team win prestigious Royal Society of Chemistry Prize The A∙WOL antifilarial drug discovery team has been named the winner of the Royal Society of Chemistry's Horizon Prize, which celebrates discoveries...
News article LSTM researcher receives Academy of Medical Sciences Springboard Award for a project investigating drug resistance in E. Coli From: LSTM LSTM researcher receives Academy of Medical Sciences Springboard Award for a project investigating drug resistance in E. Coli The Academy of Medical Sciences (AMS) has awarded £125,000 to Dr Thomas Edwards at Liverpool School of Tropical Medicine (LSTM) to support his...
A graphic showing how graphene molecules might look under a microsope. News article Cutting-edge graphene 'lab on a chip' medical diagnostic technology investigated in new project From: LSTM Cutting-edge graphene 'lab on a chip' medical diagnostic technology investigated in new project A new project will investigate how advanced graphene technology could be utilised to rapidly detect infection and act as the basis for new medical...
Image of laboratory News article LSTM's Centre for Drugs and Diagnostics awarded close to £10m to aid expansion From: LSTM LSTM's Centre for Drugs and Diagnostics awarded close to £10m to aid expansion Research England has awarded £9.8 million to the Centre for Drugs and Diagnostics (CDD) at Liverpool School of Tropical Medicine (LSTM) to train the...
News article New drug treatment could reduce malaria rates for pregnant women with HIV From: LSTM New drug treatment could reduce malaria rates for pregnant women with HIV A new drug treatment could help to prevent malaria during pregnancy for women living with HIV, new research suggests.
A saw scaled viper (Image: R Wilson) News article New drug combinations raise hopes of effective, locally administered snakebite treatment From: LSTM New drug combinations raise hopes of effective, locally administered snakebite treatment New drug combinations could protect snakebite victims from the devastating, life-changing injuries caused by toxic venom, promising new research led...
E.coli samples News article New research aims to prevent transmission of enteric bacteria and tackle antimicrobial resistance From: LSTM New research aims to prevent transmission of enteric bacteria and tackle antimicrobial resistance New research seeks to better understand where and how Escherichia coli is acquired, enabling more effective interventions to prevent transmission and...
Plaque assays which are done to quantify virus infectivity News article Molecular compound does not generate antiviral response to COVID infection, study shows From: LSTM Molecular compound does not generate antiviral response to COVID infection, study shows A type of drug that had been suggested as a potential COVID-19 treatment may not be clinically useful, a study led by Liverpool School of Tropical...
News article Search for effective CCHF Treatments: first patient dosed in novel clinical trial platform in Turkiye From: LSTM Search for effective CCHF Treatments: first patient dosed in novel clinical trial platform in Turkiye July 18th 2023 –Liverpool School of Tropical Medicine (LSTM) and Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital in Ankara...
News article A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes. From: LSTM A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes. A large multi-country trial of 4680 women in sub-Sahara Africa, looking at new antimalarial treatment for pregnant women in Africa, led by Prof....
News article Liverpool School of Tropical Medicine awarded £4.7 million to establish a new Human Challenge Facility, for infectious disease research From: LSTM Liverpool School of Tropical Medicine awarded £4.7 million to establish a new Human Challenge Facility, for infectious disease research LiverpoolSchool of Tropical Medicine (LSTM) is celebrating being awarded £4.7 million in funding from the Research England Development (RED) Fund....
News article LSTM and MLW researchers part of team calling for simpler diagnostic tools for chronic hepatitis B patients in Africa From: LSTM LSTM and MLW researchers part of team calling for simpler diagnostic tools for chronic hepatitis B patients in Africa A group of international researchers, including those from Liverpool School of Tropical Medicine (LSTM) and the Malawi Liverpool Welcome Trust (MLW...